GURUFOCUS.COM » STOCK LIST » Latin America » Mexico » MEX » Bionano Genomics Inc (MEX:BNGO) » Definitions » Total Stockholders Equity
Switch to:

Bionano Genomics (MEX:BNGO) Total Stockholders Equity

: MXN4,891.9 Mil (As of Dec. 2022)
View and export this data going back to 2021. Start your Free Trial

Bionano Genomics's Total Stockholders Equity for the quarter that ended in Dec. 2022 was MXN4,891.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bionano Genomics's Book Value per Share for the quarter that ended in Dec. 2022 was MXN16.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bionano Genomics's Debt-to-Equity for the quarter that ended in Dec. 2022 was 0.05.


Bionano Genomics Total Stockholders Equity Historical Data

The historical data trend for Bionano Genomics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Stockholders Equity
Premium Member Only Premium Member Only 203.73 69.04 700.25 7,054.53 4,891.89

Bionano Genomics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,054.53 6,393.11 5,697.56 5,654.25 4,891.89

Bionano Genomics  (MEX:BNGO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bionano Genomics's Book Value per Share for the quarter that ended in Dec. 2022 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bionano Genomics's Debt-to-Equity for the quarter that ended in Dec. 2022 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionano Genomics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionano Genomics (MEX:BNGO) Business Description

Bionano Genomics logo
Traded in Other Exchanges
Address
9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Bionano Genomics (MEX:BNGO) Headlines

From GuruFocus

Other Sources